How many acquisitions has Astellas Pharma made so far?

Astellas Pharma has completed 15 acquisitions so far, with an average acquisition amount of $1.19B.

Which countries does Astellas Pharma usually acquire in?

Astellas Pharma has made acquisitions in 4 countries with the most activity in United States and United Kingdom.

Which is Astellas Pharma's latest acquisition?

Astellas Pharma's most recent acquisition is Propella Therapeutics, a Developer of therapeutics for cancer and arthritis, acquired in December 2023 for $175M.

Which sectors does Astellas Pharma target for acquisitions?

Most of Astellas Pharma's acquisitions are in Oncology (6) and Genomics (3).

In which year did Astellas Pharma make the most acquisitions?

Astellas Pharma was most active in 2018, with 3 acquisitions completed in that year.

List of 15 Acquisitions by Astellas Pharma (Apr 2026)

Most viewed in 2019

Astellas Pharma has completed a total of 15 acquisitions. Peak activity occurred in 2018 with 3 acquisitions; 2 acquisitions each were completed in 2023 and 2020. These acquisitions have spanned 4 countries: United States (11), United Kingdom (2), and Germany (1). The acquisitions have engaged 13 sectors, with notable activity in Oncology (6), Genomics (3), and Ophthalmology (3). Over the last five years (2020–2025), the average number of acquisitions per year is 0.4. So far, 0 acquisitions have been completed in the current calendar year. The most recent acquisition, completed in December 2023 for $175M, was Propella Therapeutics, a Pittsboro-based developer of therapeutics for cancer and arthritis, founded in 2020.

Here's the year on year acquisition history of Astellas Pharma:

Number of Total Acquisitions

Year	# Acquisitions
2023	2
2020	2
2019	2
2018	3
2017	1
2016	1
2015	2
2010	1
2007	1

View all Acquisitions by Astellas Pharma

Recent acquisitions by Astellas Pharma

Astellas Pharma's most recent acquisition - Propella Therapeutics is a Developer of therapeutics for cancer and arthritis, founded in 2020 and located in Pittsboro. Astellas Pharma acquired a 100% stake in it in December 2023 for a price of $*****.

Here is the list of all acquisitions by Astellas Pharma sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Dec 22, 2023	Propella Therapeutics	wjvd	vdcz	88	971
Apr 29, 2023	IVERIC bio	yssx	jaka	35	341
Oct 14, 2020	iota Biosciences	ooeu	{kky	82	479
Apr 22, 2020	Nanna Therapeutics	btye	nspa	54	903
Dec 26, 2019	Xyphos	twjj	kawe	39	879